Mir Lluis M
CNRS UMR 8121, Institut Gustave-Roussy, Univ Paris-Sud, 8121, Villejuif, UMR, France.
Methods Mol Biol. 2008;423:3-17. doi: 10.1007/978-1-59745-194-9_1.
Twenty-five years after the publication of the first report on gene transfer in vitro in cultured cells by the means of electric pulse delivery, reversible cell electroporation for gene transfer and gene therapy (DNA electrotransfer) is at a crossroad in its development. Present knowledge on the effects of cell exposure to appropriate electric field pulses, particularly at the level of the cell membrane, is reported here as an introduction to the large range of applications described in this book. The importance of the models of electric field distribution in tissues and of the correct choice of electrodes and applied voltages is highlighted. The mechanisms involved in DNA electrotransfer, which include cell electropermeabilization and DNA electrophoresis, are also surveyed. The feasibility of electric pulse for gene transfer in humans is discussed taking into account that electric pulse delivery is already regularly used for localized drug delivery in the treatment of cutaneous and subcutaneous solid tumors by electrochemotherapy. Because recent technological developments have made DNA electrotransfer more efficient and safer, this nonviral gene therapy approach is now ready to reach the clinical stage. A good understanding of DNA electrotransfer principles and a respect for safe procedures will be key elements for the successful future transition of DNA electrotransfer to the clinics.
在通过电脉冲递送在培养细胞中进行体外基因转移的首份报告发表25年后,用于基因转移和基因治疗的可逆细胞电穿孔(DNA电转染)正处于其发展的十字路口。本文报道了目前关于细胞暴露于适当电场脉冲的影响的知识,特别是在细胞膜水平上的影响,以此作为对本书中所述广泛应用的介绍。强调了组织中电场分布模型以及电极和施加电压的正确选择的重要性。还综述了DNA电转染所涉及的机制,包括细胞电通透化和DNA电泳。考虑到电脉冲递送已常规用于通过电化学疗法治疗皮肤和皮下实体瘤的局部药物递送,讨论了电脉冲用于人类基因转移的可行性。由于最近的技术发展使DNA电转染更高效、更安全,这种非病毒基因治疗方法现已准备好进入临床阶段。对DNA电转染原理的充分理解和对安全程序的遵守将是DNA电转染未来成功过渡到临床的关键因素。